Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinical trials

Author： Hilton J.   Bouganim N.   Dong B.   Chapman J.   Arnaout A.   O’Malley F.   Gelmon K.   Yerushalmi R.   Levine M.   Bramwell V.   Whelan T.   Pritchard K.   Shepherd L.   Clemons M.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.142, Iss.1, 2013-11, pp. : 143-151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1

By Sawka C.A.  

Breast Cancer Research and Treatment, Vol. 44, Iss. 3, 1997-07 ,pp. : 211-215

Springer Publishing Company

Access to resources Recommend Favorite

Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial

By O’Malley F.   Chia S.   Tu D.   Shepherd L.   Levine M.   Huntsman D.   Bramwell V.   Andrulis I.   Pritchard K.  

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 401-409

Springer Publishing Company

Access to resources Recommend Favorite

Quality of Life Analyses in a Clinical Trial of DPPE (tesmilifene) Plus Doxorubicin Versus Doxorubicin in Patients with Advanced or Metastatic Breast Cancer: NCIC CTG Trial MA.19

By Liu Jianhua   Tu Dongsheng   Dancey Janet   Reyno Leonard   Pritchard Kathleen I.   Pater Joseph   Seymour Lesley K  

Breast Cancer Research and Treatment, Vol. 100, Iss. 3, 2006-12 ,pp. : 263-271

Springer Publishing Company

Access to resources Recommend Favorite

Breast Conservation in Women with Multifocal-Multicentric Breast Cancer: Is It Feasible?

By Bauman Laura   Barth Richard   Rosenkranz Kari  

Annals of Surgical Oncology, Vol. 17, Iss. 3, 2010-10 ,pp. : 325-329

Springer Publishing Company

Access to resources Recommend Favorite

Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial

By Ingle James   Tu Dongsheng   Pater Joseph   Martino Silvana   Robert Nicholas   Muss Hyman   Piccart Martine   Castiglione Monica   Shepherd Lois   Pritchard Kathleen   Livingston Robert   Davidson Nancy   Norton Larry   Perez Edith   Abrams Jeffrey   Cameron David   Palmer Michael   Goss Paul  

Breast Cancer Research and Treatment, Vol. 99, Iss. 3, 2006-10 ,pp. : 295-300

Springer Publishing Company

Access to resources Recommend Favorite